Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Published in: Current Atherosclerosis Reports 10/2023

30-08-2023 | COVID-19

The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review

Authors: Tanusha S. Tholla, Caleigh M. Sawicki, Shilpa N. Bhupathiraju

Published in: Current Atherosclerosis Reports | Issue 10/2023

Login to get access

Abstract

Purpose of Review

Cardiovascular disease (CVD) is one of the top comorbidities associated with COVID-19—both pre- and post-infection. This review examines the relationships between COVID-19 infection and cardiovascular health, with a specific focus on diet as an important modifiable risk factor.

Recent Findings

Pandemic era studies of individuals battling and recovering from COVID-19 infection suggest a strong link between metabolic diseases, such as CVD, and SARS-CoV-2 infection susceptibility and severity. Other studies also demonstrate how COVID-19 lockdown policies and quarantine recommendations led to drastic lifestyle changes associated with increased CVD risk, such as reduced physical activity and lower diet quality. At the same time, new research is emerging that plant-based diets, which have previously been associated with lower CVD risk, may lower COVID-19 infection rates and severity of symptoms.

Summary

Diet, COVID-19, and CVD intersect through complex biological mechanisms and related behavioral factors evidenced by clinical trials and epidemiological studies. Diet may be a critical tool for modifying risk of communicable and non-communicable conditions in the post-pandemic world.
Literature
1.
2.
Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected — obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021;17:135–49.PubMedCrossRef
3.
Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab. 2020;22:1915–24.PubMedPubMedCentralCrossRef
4.
Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infect Control. 2021;49:238–46.PubMedCrossRef
5.••
Kompaniyets L, Pennington AF, Goodman AB, et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021. Prev Chronic Dis. 2021;18:E66. https://​doi.​org/​10.​5888/​pcd18.​210123. A review of underlying medical conditions and comorbidities among almost 5 million hospitalized COVID-19 patients in the U.S., to predict risk factors of severe infection.
6.
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020;92:1875–83.PubMedPubMedCentralCrossRef
7.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21:855.PubMedPubMedCentralCrossRef
8.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811–8.PubMedCrossRef
9.
10.
11.
Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis. Eur Heart J 2021:ehab696. https://​doi.​org/​10.​1093/​eurheartj/​ehab696.
12.
13.••
Merino J, Joshi AD, Nguyen LH, Leeming ER, Mazidi M, Drew DA, et al. Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut. 2021;70:2096–104. This is one of the largest cohort studies that examined the relationship between dietary factors and COVID-19 symptoms.PubMedCrossRef
14.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596-646.PubMedPubMedCentral
15.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726.PubMedCrossRef
16.•
Azevedo RB, Botelho BG, de Hollanda JVG, Ferreira LVL, de Junqueira Andrade LZ, Oei SSML, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35:4–11. A review of the pathophysiology of COVID-19 and its impact and implications on cardiovascular disease and the cardiovascular system.PubMedCrossRef
17.
Liang C, Zhang W, Li S, Qin G. Coronary heart disease and COVID-19: a meta-analysis. Med Clin (Barc). 2021;156:547–54.PubMedCrossRef
18.
Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33:373–4.PubMedCrossRef
19.
Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:1–8.CrossRef
20.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141:1648–55.PubMedCrossRef
21.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543–58.PubMedPubMedCentralCrossRef
22.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond Engl. 2020;395:1054–62.CrossRef
23.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA Cardiol. 2020;5:802–10.PubMedCrossRef
24.
Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the cardiovascular system: a review of available reports. Cardiovasc Drugs Ther. 2021;35:411–25.PubMedCrossRef
25.
Maestrini V, Birtolo LI, Francone M, Galardo G, Galea N, Severino P, et al. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up. Int J Cardiol. 2021;339:235–42.PubMedPubMedCentralCrossRef
26.
Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R. Fluid and electrolyte disturbances in COVID-19 and their complications. BioMed Res Int. 2021;2021:6667047.PubMedPubMedCentralCrossRef
27.
Severino P, D’Amato A, Prosperi S, Myftari V, Labbro Francia A, Önkaya M, et al. The mutual relationship among cardiovascular diseases and COVID-19: focus on micronutrients imbalance. Nutrients. 2022;14:3439.PubMedPubMedCentralCrossRef
28.
Chimenti C, Magnocavallo M, Ballatore F, Bernardini F, Alfarano M, Della Rocca DG, et al. Prevalence and clinical implications of COVID-19 myocarditis. Card Electrophysiol Clin. 2022;14:53–62.PubMedCrossRef
29.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.PubMedPubMedCentralCrossRef
30.
Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129:446.e5-446.e21.PubMedCrossRef
31.
Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD, et al. Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I. Am J Med. 2017;130:1431-1439.e4.PubMedCrossRef
32.
Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin. 2021;53:273–82.PubMedCrossRef
33.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9.PubMedCrossRef
34.
Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2: a double-edged sword. Circulation. 2020;142:426–8.PubMedCrossRef
35.
Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complicat. 2021;35:107817.CrossRef
36.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet (London, England). Lancet. 2021;398:957–80. https://​doi.​org/​10.​1016/​S0140-6736(21)01330-1.
37.
Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, et al. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertens Dallas Tex. 1979;2020(76):366–72.
38.
Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2021;40:905–19.CrossRef
39.
Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin E Investig En Arterioscler Publicacion Soc Espanola Arterioscler. 2021;33:151–7.CrossRef
40.
de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr. 2020;12:75.PubMedPubMedCentralCrossRef
41.
Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020;142:4–6.PubMedCrossRef
42.
Powell-Wiley TM, Poirier P, Burke LE, Després J-P, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:e984-1010.PubMedPubMedCentralCrossRef
43.•
Freuer D, Linseisen J, Meisinger C. Impact of body composition on COVID-19 susceptibility and severity: a two-sample multivariable Mendelian randomization study. Metabolism. 2021;118:154732. A two-sample Mendelian randomization study suggesting obesity, a common CVD comorbidity, to be a strong risk factor for severe COVID-19 infection.PubMedPubMedCentralCrossRef
44.
Huang J-F, Wang X-B, Zheng KI, Liu W-Y, Chen J-J, George J, et al. Letter to the editor: obesity hypoventilation syndrome and severe COVID-19. Metabolism. 2020;108:154249.PubMedPubMedCentralCrossRef
45.
46.
47.••
Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144:e472–87. This is a scientific statement from the American Heart Association with comprehensive evidence-based guidance on dietary recommendations for cardiovascular health.PubMedCrossRef
48.
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34.PubMedCrossRef
49.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.PubMedCrossRef
50.
Conlin PR, Erlinger TP, Bohannon A, Miller ER, Appel LJ, Svetkey LP, et al. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am J Hypertens. 2003;16:337–42.PubMedCrossRef
51.
Louca P, Murray B, Klaser K, Graham MS, Mazidi M, Leeming ER, et al. Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app. BMJ Nutr Prev Health. 2021;4:149–57.PubMedPubMedCentralCrossRef
52.
Daboul SM, Abusamak M, Mohammad BA, Alsayed AR, Habash M, Mosleh I, et al. The effect of omega-3 supplements on the serum levels of ACE/ACE2 ratio as a potential key in cardiovascular disease: a randomized clinical trial in participants with vitamin D deficiency. Pharm Pract. 2023;21:2761.
53.
Olczak-Pruc M, Szarpak L, Navolokina A, Chmielewski J, Panasiuk L, Juárez-Vela R, et al. The effect of zinc supplementation on the course of COVID-19 - a systematic review and meta-analysis. Ann Agric Environ Med AAEM. 2022;29:568–74.PubMedCrossRef
54.
Olczak-Pruc M, Swieczkowski D, Ladny JR, Pruc M, Juarez-Vela R, Rafique Z, et al. Vitamin C supplementation for the treatment of COVID-19: a systematic review and meta-analysis. Nutrients. 2022;14:4217.PubMedPubMedCentralCrossRef
55.
Hosseini B, El Abd A, Ducharme FM. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis. Nutrients. 2022;14:2134.PubMedPubMedCentralCrossRef
56.
Zhang Y, Li J, Yang M, Wang Q. Effect of vitamin D supplementation on COVID-19 patients: a systematic review and meta-analysis. Front Nutr. 2023;10:1131103.PubMedPubMedCentralCrossRef
57.
Kümmel LS, Krumbein H, Fragkou PC, Hünerbein BL, Reiter R, Papathanasiou KA, et al. Vitamin D supplementation for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. Front Immunol. 2022;13:1023903.PubMedPubMedCentralCrossRef
58.•
Zamanian A, Yari Z, Soltanieh S, Salavatizadeh M, Karimi S, Ardestani SK, et al. The association of dietary approach to stop hypertension (DASH) diet with hospitalization risk in patients with COVID-19. Clin Nutr Open Sci. 2023;48:55–63. A study on the Dietary Approaches to Stop Hypertension (DASH) diet among 141 COVID-19 patients that provided strong association between adherence to the diet and lower COVID-19 severity.PubMedPubMedCentralCrossRef
59.
Ponzo V, Pellegrini M, D’Eusebio C, Bioletto F, Goitre I, Buscemi S, et al. Mediterranean diet and SARS-CoV-2 infection: is there any association? A proof-of-concept study. Nutrients. 2021;13:1721.PubMedPubMedCentralCrossRef
60.•
Perez-Araluce R, Martinez-Gonzalez MA, Fernández-Lázaro CI, Bes-Rastrollo M, Gea A, Carlos S. Mediterranean diet and the risk of COVID-19 in the “Seguimiento Universidad de Navarra” cohort. Clin Nutr Edinb Scotl. 2022;41:3061–8. A study on the Seguimiento Universidad de Navarra (SUN) cohort with over 5,100 participants that showed an association between Mediterranean Diet adherence and lower COVID-19 infection severity.CrossRef
61.
Perez-Araluce R, Martínez-González MÁ, Gea A, Carlos S. Components of the Mediterranean diet and risk of COVID-19. Front Nutr. 2021;8:805533.PubMedCrossRef
62.
Ebrahimzadeh A, Taghizadeh M, Milajerdi A. Major dietary patterns in relation to disease severity, symptoms, and inflammatory markers in patients recovered from COVID-19. Front Nutr. 2022;9:929384.PubMedPubMedCentralCrossRef
63.
Zargarzadeh N, Tadbir Vajargah K, Ebrahimzadeh A, Mousavi SM, Khodaveisi H, Akhgarjand C, et al. Higher adherence to the Mediterranean dietary pattern is inversely associated with severity of COVID-19 and related symptoms: a cross-sectional study. Front Med. 2022;9:911273.CrossRef
64.
Tadbir Vajargah K, Zargarzadeh N, Ebrahimzadeh A, Mousavi SM, Mobasheran P, Mokhtari P, et al. Association of fruits, vegetables, and fiber intake with COVID-19 severity and symptoms in hospitalized patients: a cross-sectional study. Front Nutr. 2022;9:934568.PubMedPubMedCentralCrossRef
65.
Yue Y, Ma W, Accorsi EK, Ding M, Hu F, Willett WC, et al. Long-term diet and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity. Am J Clin Nutr. 2022;116:1672–81.PubMedCrossRef
66.
Rahmati M, Fatemi R, Yon DK, Lee SW, Koyanagi A, Il Shin J, et al. The effect of adherence to high-quality dietary pattern on COVID-19 outcomes: a systematic review and meta-analysis. J Med Virol. 2023;95:e28298.PubMedCrossRef
67.
Kamyari N, Soltanian AR, Mahjub H, Moghimbeigi A. Diet, nutrition, obesity, and their implications for COVID-19 mortality: development of a marginalized two-part model for semicontinuous data. JMIR Public Health Surveill. 2021;7:e22717.PubMedPubMedCentralCrossRef
68.
Li F, Hou L, Chen W, Chen P, Lei C, Wei Q, et al. Associations of dietary patterns with the risk of all-cause, CVD and stroke mortality: a meta-analysis of prospective cohort studies. Br J Nutr. 2015;113:16–24.PubMedCrossRef
69.
Jayedi A, Soltani S, Abdolshahi A, Shab-Bidar S. Healthy and unhealthy dietary patterns and the risk of chronic disease: an umbrella review of meta-analyses of prospective cohort studies. Br J Nutr. 2020;124:1133–44.PubMedCrossRef
70.
71.
Tashiro H, Takahashi K, Sadamatsu H, Kato G, Kurata K, Kimura S, et al. Saturated fatty acid increases lung macrophages and augments house dust mite-induced airway inflammation in mice fed with high-fat diet. Inflammation. 2017;40:1072–86.PubMedCrossRef
72.
Milner JJ, Rebeles J, Dhungana S, Stewart DA, Sumner SCJ, Meyers MH, et al. Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol Baltim Md. 1950;2015(194):4846–59.
73.
74.
Fardet A, Boirie Y. Associations between diet-related diseases and impaired physiological mechanisms: a holistic approach based on meta-analyses to identify targets for preventive nutrition. Nutr Rev. 2013;71:643–56.PubMedCrossRef
75.
Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007;44:335–40.PubMedCrossRef
76.
77.••
Mignogna C, Costanzo S, Ghulam A, Cerletti C, Donati MB, de Gaetano G, et al. Impact of nationwide lockdowns resulting from the first wave of the COVID-19 pandemic on food intake, eating behaviours and diet quality: a systematic review. Adv Nutr Bethesda Md. 2021;13:388–423. Review of dietary habit and eating behavior changes worldwide as a result of COVID-19 pandemic lockdowns that showed greater food intake and overall moderate improvement in diet quality.CrossRef
78.
Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attinà A, Cinelli G, et al. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med. 2020;18:229.PubMedPubMedCentralCrossRef
79.
Ruiz-Roso MB, de Carvalho PP, Mantilla-Escalante DC, Ulloa N, Brun P, Acevedo-Correa D, et al. Covid-19 confinement and changes of adolescent’s dietary trends in Italy, Spain, Chile Colombia and Brazil. Nutrients. 2020;12:1807.PubMedPubMedCentralCrossRef
80.
Karatzi K, Poulia K-A, Papakonstantinou E, Zampelas A. The impact of nutritional and lifestyle changes on body weight, body composition and cardiometabolic risk factors in children and adolescents during the pandemic of COVID-19: a systematic review. Child Basel Switz. 2021;8:1130.
81.
Daniels NF, Burrin C, Chan T, Fusco F. A systematic review of the impact of the first year of COVID-19 on obesity risk factors: a pandemic fueling a pandemic? Curr Dev Nutr. 2022;6:nzac011.PubMedPubMedCentralCrossRef
82.
Mattioli AV, Sciomer S, Cocchi C, Maffei S, Gallina S. Quarantine during COVID-19 outbreak: changes in diet and physical activity increase the risk of cardiovascular disease. Nutr Metab Cardiovasc Dis NMCD. 2020;30:1409–17.PubMedCrossRef
83.••
Crowder SL, Beckie T, Stern M. A review of food insecurity and chronic cardiovascular disease: implications during the COVID-19 pandemic. Ecol Food Nutr. 2021;60:596–611. A review examining the social determinants of health and food access that affect cardiovascular disease management during the COVID-19 pandemic.PubMedPubMedCentralCrossRef
84.
85.
86.
Larson N, Slaughter-Acey J, Alexander T, Berge J, Harnack L, Neumark-Sztainer D. Emerging adults’ intersecting experiences of food insecurity, unsafe neighbourhoods and discrimination during the coronavirus disease 2019 (COVID-19) outbreak. Public Health Nutr. 2021;24:519–30.PubMedCrossRef
87.
Duska F, Andel M, Kubena A, Macdonald IA. Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus. Clin Nutr Edinb Scotl. 2005;24:1056–64.CrossRef
88.
Wang SY, Eberly LA, Roberto CA, Venkataramani AS, Groeneveld PW, Khatana SAM. Food insecurity and cardiovascular mortality for nonelderly adults in the United States from 2011 to 2017: a county-level longitudinal analysis. Circ Cardiovasc Qual Outcomes. 2021;14:e007473.PubMedCrossRef
89.
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993–8.PubMedPubMedCentralCrossRef
90.
91.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.
92.
Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in “long COVID”: rationale, physiology and management strategies. Clin Med Lond Engl. 2021;21:e63–7.CrossRef
93.
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013–22.PubMedCrossRef
94.
95.
Metadata
Title
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review
Authors
Tanusha S. Tholla
Caleigh M. Sawicki
Shilpa N. Bhupathiraju
Publication date
30-08-2023
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 10/2023
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-023-01138-7

Other articles of this Issue 10/2023

Current Atherosclerosis Reports 10/2023 Go to the issue

ReviewPaper

Treatment of Lp(a): Is It the Future or Are We Ready Today?

ReviewPaper

Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies

ReviewPaper

Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries

ReviewPaper

Fixed Combination for the Treatment of Dyslipidaemia

ReviewPaper

The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis

ReviewPaper

The TICE Pathway: Mechanisms and Potential Clinical Applications
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits